关注
Ingrid Sketris
Ingrid Sketris
Professor, College of Pharmacy, Dalhousie University
在 dal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management
E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ...
Health policy 119 (5), 628-639, 2015
5142015
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic …
B Hill‐Taylor, I Sketris, J Hayden, S Byrne, D O'sullivan, R Christie
Journal of clinical pharmacy and therapeutics 38 (5), 360-372, 2013
5042013
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney …
K Mahalati, P Belitsky, I Sketris, K West, R Panek
Transplantation 68 (1), 55-62, 1999
4941999
Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria …
B Hill‐Taylor, KA Walsh, S Stewart, J Hayden, S Byrne, IS Sketris
Journal of clinical pharmacy and therapeutics 41 (2), 158-169, 2016
2802016
Identifying, understanding and overcoming barriers to medication error reporting in hospitals: a focus group study
N Hartnell, N MacKinnon, I Sketris, M Fleming
BMJ quality & safety 21 (5), 361-368, 2012
2592012
A comparison of health utility measures for the evaluation of multiple sclerosis treatments
JD Fisk, MG Brown, IS Sketris, LM Metz, TJ Murray, KJ Stadnyk
Journal of Neurology, Neurosurgery & Psychiatry 76 (1), 58-63, 2005
2322005
Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study
K Mahalati, P Belitsky, K West, B Kiberd, A Fraser, I Sketris, ...
Journal of the American Society of Nephrology 12 (4), 828-833, 2001
2272001
CNODES: the Canadian network for observational drug effect studies
S Suissa, D Henry, P Caetano, CR Dormuth, P Ernst, B Hemmelgarn, ...
Open Medicine 6 (4), e134, 2012
1702012
A limited sampling strategy for the measurement of cyclosporine AUC
A Johnston, I Sketris, JT Marsden, CG Galustian, T Fashola, D Taube, ...
Transplantation proceedings 22 (3), 1345-1346, 1990
1271990
Optimizing scopes of practice: New models of care for a new health care system
S Nelson, J Turnbull, L Bainbridge, T Caulfield, G Hudon, D Kendel, ...
Canadian Academy of Health Sciences, 2014
1232014
Factors affecting compliance with cyclosporine in adult renal transplant patients.
I Sketris, N Waite, K Grobler, M West, S Gerus
Transplantation proceedings 26 (5), 2538-2541, 1994
1211994
Independent pharmacist prescribing in Canada
MR Law, T Ma, J Fisher, IS Sketris
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145 (1), 17-23. e1, 2012
1192012
Strategic opportunities for effective optimal prescribing and medication management
IS Sketris, EM Langille Ingram, HL Lummis
Can J Clin Pharmacol 16 (1), e103-25, 2009
1132009
Societal costs of vascular cognitive impairment in older adults
K Rockwood, M Brown, H Merry, I Sketris, J Fisk
Stroke 33 (6), 1605-1609, 2002
1132002
Association between incretin-based drugs and the risk of acute pancreatitis
L Azoulay, KB Filion, RW Platt, M Dahl, CR Dormuth, KK Clemens, ...
JAMA internal medicine 176 (10), 1464-1473, 2016
1122016
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
MG Brown, S Kirby, C Skedgel, JD Fisk, TJ Murray, V Bhan, IS Sketris
Neurology 69 (15), 1498-1507, 2007
1012007
Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study
R Clark, JE Fisher, IS Sketris, GM Johnston
BMC clinical pharmacology 12, 1-8, 2012
992012
Prescription drug samples–does this marketing strategy counteract policies for quality use of medicines?
KEM Groves, I Sketris, SE Tett
Journal of clinical pharmacy and therapeutics 28 (4), 259-271, 2003
942003
Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal …
J Zacny, M Zamakhshary, I Sketris, S Veldhuyzen van Zanten
Alimentary pharmacology & therapeutics 21 (11), 1299-1312, 2005
842005
Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary
E Reeve, B Farrell, W Thompson, N Herrmann, I Sketris, PJ Magin, ...
Medical Journal of Australia 210 (4), 174-179, 2019
832019
系统目前无法执行此操作,请稍后再试。
文章 1–20